Cargando…

Clinical assessment of the therapeutic effect of low-level laser therapy on chronic recurrent aphthous stomatitis

The aim of this study was to clinically assess the therapeutic effect of low-level laser therapy (LLLT) on chronic recurrent aphthous stomatitis (RAS) using a protocol we developed especially for the purpose. The study included 180 patients: group 1 (the study group) – 90 patients who received LLLT...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalabonova, Hristina, Daskalov, Hristo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433909/
https://www.ncbi.nlm.nih.gov/pubmed/26019580
http://dx.doi.org/10.1080/13102818.2014.966526
_version_ 1782371683942793216
author Lalabonova, Hristina
Daskalov, Hristo
author_facet Lalabonova, Hristina
Daskalov, Hristo
author_sort Lalabonova, Hristina
collection PubMed
description The aim of this study was to clinically assess the therapeutic effect of low-level laser therapy (LLLT) on chronic recurrent aphthous stomatitis (RAS) using a protocol we developed especially for the purpose. The study included 180 patients: group 1 (the study group) – 90 patients who received LLLT using a laser operating in the red spectrum (658 nm; in a non-contact mode; power output P = 27 mW; frequency f (1) = 5.8 Hz, f (2) – continuous waveform; time T = 1.14 min; dosage of 2 J/cm(2) once daily); group 2 (controls) – 90 patients who received pharmacotherapy (Granofurin and solcoseryl given twice daily). The indices we assessed were pain intensity, erythema dynamics and epithelization time. Pain was completely managed in 55.6% of group 1 patients one day after therapy began, while it took three days to alleviate pain for 11.1% of the patients in group 2. The erythema was managed entirely in 24.4% of group 1 patients after the first session, while it did not change in any of the group 2 patients. Pain intensity and erythema had similar dynamics for both groups. In 5 days, 75.6% of group 1 patients showed complete epithelization, while in group 2 the process was completed in only 37.8% of patients. As a whole, the results we obtained using LLLT to treat chronic RAS were better than those obtained in the group receiving pharmacotherapy. Pain and inflammation were very effectively managed with LLLT with the parameters we used and epithelization was considerably accelerated.
format Online
Article
Text
id pubmed-4433909
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-44339092015-05-25 Clinical assessment of the therapeutic effect of low-level laser therapy on chronic recurrent aphthous stomatitis Lalabonova, Hristina Daskalov, Hristo Biotechnol Biotechnol Equip Article; Medical Biotechnology The aim of this study was to clinically assess the therapeutic effect of low-level laser therapy (LLLT) on chronic recurrent aphthous stomatitis (RAS) using a protocol we developed especially for the purpose. The study included 180 patients: group 1 (the study group) – 90 patients who received LLLT using a laser operating in the red spectrum (658 nm; in a non-contact mode; power output P = 27 mW; frequency f (1) = 5.8 Hz, f (2) – continuous waveform; time T = 1.14 min; dosage of 2 J/cm(2) once daily); group 2 (controls) – 90 patients who received pharmacotherapy (Granofurin and solcoseryl given twice daily). The indices we assessed were pain intensity, erythema dynamics and epithelization time. Pain was completely managed in 55.6% of group 1 patients one day after therapy began, while it took three days to alleviate pain for 11.1% of the patients in group 2. The erythema was managed entirely in 24.4% of group 1 patients after the first session, while it did not change in any of the group 2 patients. Pain intensity and erythema had similar dynamics for both groups. In 5 days, 75.6% of group 1 patients showed complete epithelization, while in group 2 the process was completed in only 37.8% of patients. As a whole, the results we obtained using LLLT to treat chronic RAS were better than those obtained in the group receiving pharmacotherapy. Pain and inflammation were very effectively managed with LLLT with the parameters we used and epithelization was considerably accelerated. Taylor & Francis 2014-09-03 2014-10-21 /pmc/articles/PMC4433909/ /pubmed/26019580 http://dx.doi.org/10.1080/13102818.2014.966526 Text en © 2014 The Author(s). Published by Taylor & Francis. http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Article; Medical Biotechnology
Lalabonova, Hristina
Daskalov, Hristo
Clinical assessment of the therapeutic effect of low-level laser therapy on chronic recurrent aphthous stomatitis
title Clinical assessment of the therapeutic effect of low-level laser therapy on chronic recurrent aphthous stomatitis
title_full Clinical assessment of the therapeutic effect of low-level laser therapy on chronic recurrent aphthous stomatitis
title_fullStr Clinical assessment of the therapeutic effect of low-level laser therapy on chronic recurrent aphthous stomatitis
title_full_unstemmed Clinical assessment of the therapeutic effect of low-level laser therapy on chronic recurrent aphthous stomatitis
title_short Clinical assessment of the therapeutic effect of low-level laser therapy on chronic recurrent aphthous stomatitis
title_sort clinical assessment of the therapeutic effect of low-level laser therapy on chronic recurrent aphthous stomatitis
topic Article; Medical Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433909/
https://www.ncbi.nlm.nih.gov/pubmed/26019580
http://dx.doi.org/10.1080/13102818.2014.966526
work_keys_str_mv AT lalabonovahristina clinicalassessmentofthetherapeuticeffectoflowlevellasertherapyonchronicrecurrentaphthousstomatitis
AT daskalovhristo clinicalassessmentofthetherapeuticeffectoflowlevellasertherapyonchronicrecurrentaphthousstomatitis